Gene · 50652
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. | MedComm (2020) | 2026 | 41756253 | PubTator, text mining | PubMed |
| Clinicogenomic Insights for Progression-Free Survival in Prostate Cancer. | Int J Environ Res Public Health | 2026 | 41752338 | PubTator, text mining | PubMed |
| Advancements in Artificial Intelligence (AI) for Cancer Genomics and Genetics. | Biomedicines | 2026 | 41751173 | PubTator, text mining | PubMed |
| Exosomal bioactive molecules: molecular regulation, functional heterogeneity, and translational implications in disease diagnostics and therapeutics. | Clin Exp Med | 2026 | 41748937 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer. | J Natl Cancer Cent | 2026 | 41738031 | PubTator, text mining | PubMed |
| Postmortem Serum Prostate-Specific Antigen as a Potential Marker for Prostatic Disease: A Forensic Exploratory Study. | Cureus | 2026 | 41717145 | PubTator, text mining | PubMed |
| Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer. | JU Open Plus | 2026 | 41709952 | PubTator, text mining | PubMed |
| Prostate cancer associated 3 (PCA3) is a potential indicator of the pathological grades of prostate cancer. | Discov Oncol | 2026 | 41701446 | PubTator, text mining | PubMed |
| Targeting Hsp70 triggers ferroptosis: a novel anti-cancer mechanism of a marine natural product in prostate cancer. | Nat Prod Bioprospect | 2026 | 41639515 | PubTator, text mining | PubMed |
| BioMark: biomarker analysis tool. | BMC Bioinformatics | 2026 | 41559544 | PubTator, text mining | PubMed |
| Computational frameworks for enhanced extracellular vesicle biomarker discovery. | Exp Mol Med | 2026 | 41535547 | PubTator, text mining | PubMed |
| Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery. | Biomark Res | 2026 | 41527006 | PubTator, text mining | PubMed |
| Recent advances in liquid biopsy for genitourinary cancers: A narrative review. | Histopathology | 2026 | 41384686 | PubTator, text mining | PubMed |
| Emerging biomarkers in prostate cancer diagnosis and treatment: Insights into genetic, RNA and metabolic markers (Review). | Int J Oncol | 2026 | 41347816 | PubTator, text mining | PubMed |
| The role of microrna-346 in prostate cancer progression: Clinical significance and biomarker potential. | J Med Biochem | 2025 | 41799178 | PubTator, text mining | PubMed |
| Time-Resolved Förster Resonance Energy Transfer Nanoassay Based on CdTe Quantum Dots for Sensitive Detection of Prostate Cancer Antigen 3. | ACS Appl Nano Mater | 2025 | 41574308 | PubTator, text mining | PubMed |
| Artificial Intelligence-Driven SELEX Design of Aptamer Panels for Urinary Multi-Biomarker Detection in Prostate Cancer: A Systematic and Bibliometric Review. | Biomedicines | 2025 | 41462891 | PubTator, text mining | PubMed |
| The Clinical Relevance of Tumor Biomarkers in Prostate Cancer-A Review. | Cancers (Basel) | 2025 | 41374944 | PubTator, text mining | PubMed |
| A novel biochip-based liquid biopsy for extracellular vesicle RNA detection in prostate cancer. | Cancer Biol Ther | 2025 | 41340217 | PubTator, text mining | PubMed |
| Nisin: The powerhouse metabolite of lactobacillus strains to defeat prostate cancer by targeting PCA3 lncRNA, apoptosis, and cell cycle pathways. | Folia Microbiol (Praha) | 2025 | 41105372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50652/papers?page=2